Eyestem Announces Completion of Phase One of its RPE Cell Therapy With Promising Efficacy and Safety Outcomes
Bangalore: Eyestem Research Pvt Ltd announced the completion of its phase one study for its investigational retinal pigment epithelium (RPE) cell therapy, Eyecyte-RPE. The clinical study report of the study has been submitted to the Central
